Stage IIA Prostate Cancer Terminated Phase 1 / 2 Trials for Goserelin (DB00014)

IndicationStatusPhase
DBCOND0028878 (Stage IIA Prostate Cancer)Terminated1 / 2
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT01163084Leuprolide Acetate or Goserelin Acetate With or Without Vismodegib Followed by Surgery in Treating Patients With Locally Advanced Prostate CancerTreatment